Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11910-021-01124-z http://scihub22266oqcxt.onion/10.1007/s11910-021-01124-z 34125304!8200381!34125304     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Neurol+Neurosci+Rep 2021 ; 21 (8): 41 Nephropedia Template TP {{tp|p=34125304|t=2021. Neurologic Manifestations of the Antiphospholipid Syndrome - an Update |pdf=|usr=}}{{34125304}} gab.com Text Neurologic Manifestations of the Antiphospholipid Syndrome - an Update JO: Curr Neurol Neurosci Rep http://www.kidney.de/pget.php?&tw=1&pmid=34125304 #FOAvip PURPOSE OF REVIEW: In recent years, the spectrum of neurological manifestations of antiphospholipid syndrome (APS) has been growing. We provide a critical review of the literature with special emphasis on presentation, proposed mechanisms of disease, and treatment of neurological involvement in APS. RECENT FINDINGS: Although stroke is the most common cause of neurological manifestations in patients with APS, other neurological disorders have been increasingly associated with the disease, including cognitive dysfunction, headache, and epilepsy. Direct oral anticoagulants have failed to show non-inferiority compared to vitamin K antagonists for the prevention of major thrombotic events. Antiphospholipid antibodies are often found in patients with acute COVID-19 but clear evidence supporting an association between these antibodies and the risk of thrombotic events, including stroke and cerebral venous thrombosis, is still lacking. APS patients may present with several distinct neurological manifestations. New criteria will facilitate the classification of patients presenting with increasingly recognized non-criteria neurological manifestations. Twit Text FOAVip Neurologic Manifestations of the Antiphospholipid Syndrome - an Update ????Curr Neurol Neurosci Rep http://www.kidney.de/pget.php?&tw=1&pmid=34125304 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34125304 #FOAvip English Wikipedia <ref>{{Cite pmid|34125304}}</ref> Neurologic Manifestations of the Antiphospholipid Syndrome - an Update #MMPMID34125304 Leal Rato M; Bandeira M; Romao VC; Aguiar de Sousa D Curr Neurol Neurosci Rep 2021[Jun]; 21 (8): 41 PMID34125304show ga PURPOSE OF REVIEW: In recent years, the spectrum of neurological manifestations of antiphospholipid syndrome (APS) has been growing. We provide a critical review of the literature with special emphasis on presentation, proposed mechanisms of disease, and treatment of neurological involvement in APS. RECENT FINDINGS: Although stroke is the most common cause of neurological manifestations in patients with APS, other neurological disorders have been increasingly associated with the disease, including cognitive dysfunction, headache, and epilepsy. Direct oral anticoagulants have failed to show non-inferiority compared to vitamin K antagonists for the prevention of major thrombotic events. Antiphospholipid antibodies are often found in patients with acute COVID-19 but clear evidence supporting an association between these antibodies and the risk of thrombotic events, including stroke and cerebral venous thrombosis, is still lacking. APS patients may present with several distinct neurological manifestations. New criteria will facilitate the classification of patients presenting with increasingly recognized non-criteria neurological manifestations. |*Antiphospholipid Syndrome/complications/diagnosis/drug therapy[MESH] |*COVID-19[MESH] |Antibodies, Antiphospholipid[MESH] |Anticoagulants[MESH] |Humans[MESH]Neurologic Manifestations of the Antiphospholipid Syndrome - an Update(epmc).pdf DeepDyve Pubget Overpricing